Biopsy-Proven Lupus Nephritis in a Patient Living with HIV: Autoimmunity in Immunodeficiency- A Case Report

Background The coexistence of Systemic Lupus Erythematosus (SLE) and Human Immunodeficiency Virus (HIV) infection represents a rare and complex clinical entity due to opposing immunological mechanisms. While HIV leads to immunodeficiency through CD4+ T-cell depletion, SLE is characterized by immune hyperactivity and autoantibody production. Case Presentation We report a 50-year-old female, a known Person Living with HIV (PLHIV) on Highly Active Antiretroviral Therapy (HAART), who presented with polyarthritis, alopecia, and significant weight loss. Laboratory evaluation revealed pancytopenia, markedly elevated anti-dsDNA antibodies, hypocomplementemia, and significant proteinuria. HIV disease was well controlled, with a CD4 count of 600 cells/mm 3 and a low viral load of 120 copies/mL at presentation. Renal biopsy demonstrated focal mesangial and endocapillary hypercellularity, while immunofluorescence showed granular deposition of IgG, C3, and C1q, confirming Class 3 (ISN/RPN) lupus nephritis. The patient was treated with corticosteroids, hydroxychloroquine, and mycophenolate mofetil, along with cotrimoxazole prophylaxis and continuation of HAART. On follow-up after 6 months, she achieved complete renal remission with stable HIV disease status and is currently maintained on low-dose corticosteroids, mycophenolate mofetil, hydroxychloroquine, and HAART. Conclusion This case highlights the diagnostic and therapeutic challenges of autoimmune disease in an immunocompromised host and underscores that effective viral suppression with preserved immune status permits safe and effective use of standard immunosuppressive therapy.

Authors

Institutions

Publication Details

Journal
The Open Rheumatology Journal
Published
2026-09-24
DOI
https://doi.org/10.2174/0118743129515368260922094825
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Biopsy-Proven Lupus Nephritis in a Patient Living with HIV: Autoimmunity in Immunodeficiency- A Case Report

A. S. Arun Kumar, Arul Rajamurugan Ponniah Subramanian, Dhiliprajan Kannan
The Open Rheumatology Journal
Systemic Lupus Erythematosus Research
article

Biopsy-Proven Lupus Nephritis in a Patient Living with HIV: Autoimmunity in Immunodeficiency- A Case Report

A. S. Arun Kumar, Arul Rajamurugan Ponniah Subramanian, Dhiliprajan Kannan
article en

Abstract

Background The coexistence of Systemic Lupus Erythematosus (SLE) and Human Immunodeficiency Virus (HIV) infection represents a rare and complex clinical entity due to opposing immunological mechanisms. While HIV leads to immunodeficiency through CD4+ T-cell depletion, SLE is characterized by immune hyperactivity and autoantibody production. Case Presentation We report a 50-year-old female, a known Person Living with HIV (PLHIV) on Highly Active Antiretroviral Therapy (HAART), who presented with polyarthritis, alopecia, and significant weight loss. Laboratory evaluation revealed pancytopenia, markedly elevated anti-dsDNA antibodies, hypocomplementemia, and significant proteinuria. HIV disease was well controlled, with a CD4 count of 600 cells/mm 3 and a low viral load of 120 copies/mL at presentation. Renal biopsy demonstrated focal mesangial and endocapillary hypercellularity, while immunofluorescence showed granular deposition of IgG, C3, and C1q, confirming Class 3 (ISN/RPN) lupus nephritis. The patient was treated with corticosteroids, hydroxychloroquine, and mycophenolate mofetil, along with cotrimoxazole prophylaxis and continuation of HAART. On follow-up after 6 months, she achieved complete renal remission with stable HIV disease status and is currently maintained on low-dose corticosteroids, mycophenolate mofetil, hydroxychloroquine, and HAART. Conclusion This case highlights the diagnostic and therapeutic challenges of autoimmune disease in an immunocompromised host and underscores that effective viral suppression with preserved immune status permits safe and effective use of standard immunosuppressive therapy.

The Open Rheumatology JournalVol. 20(1)
Government General Hospital (IN)
Good health and well-being
Openalex Percentile: Top 10%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.